{"transactions":[{"id":321929,"issuer":{"id":2836,"kind":"organization","name":"THERMO FISHER SCIENTIFIC INC.","symbol":"TMO"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-22T20:45:55.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":565,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3393,"source":{"system":"sec-edgar","filing":"0000097745-25-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97745/000009774525000059/form4.xml","form_type":"4"}},{"id":333428,"issuer":{"id":2836,"kind":"organization","name":"THERMO FISHER SCIENTIFIC INC.","symbol":"TMO"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-23T20:06:02.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":339,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2828,"source":{"system":"sec-edgar","filing":"0001127602-24-016371","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97745/000112760224016371/form4.xml","form_type":"4"}},{"id":348681,"issuer":{"id":2836,"kind":"organization","name":"THERMO FISHER SCIENTIFIC INC.","symbol":"TMO"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-26T21:30:37.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":392,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2489,"source":{"system":"sec-edgar","filing":"0001127602-23-016992","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97745/000112760223016992/form4.xml","form_type":"4"}},{"id":361078,"issuer":{"id":2836,"kind":"organization","name":"THERMO FISHER SCIENTIFIC INC.","symbol":"TMO"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-20T20:23:44.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":369,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2097,"source":{"system":"sec-edgar","filing":"0001127602-22-015287","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97745/000112760222015287/form4.xml","form_type":"4"}},{"id":2295633,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-18T16:15:11.000Z","date":"2022-04-14","kind":"grant","acquired":true,"shares":170989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the vesting, upon the satisfaction of the performance criteria, of a portion of a performance-based stock option originally granted on March 2, 2021."}],"balance_after":170989,"derivative":{"exercise_price":45.69,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":170989},"source":{"system":"sec-edgar","filing":"0001415889-22-004098","document":"form4-04182022_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000141588922004098/form4-04182022_040401.xml","form_type":"4"}},{"id":2447991,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-01-04T16:23:15.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":18252,"price":26.9548,"value":491979.0096,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on March 4, 2021, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 22, 2021. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":75898,"source":{"system":"sec-edgar","filing":"0001179110-22-000112","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911022000112/edgar.xml","form_type":"4"}},{"id":2459424,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-12-23T16:09:05.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":36477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the vesting, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on March 2, 2021."}],"balance_after":94150,"source":{"system":"sec-edgar","filing":"0001179110-21-011223","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911021011223/edgar.xml","form_type":"4"}},{"id":2538051,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-10-20T16:16:20.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":13805,"price":38.0321,"value":525033.1405,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on March 4, 2021, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 30, 2021. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":57673,"source":{"system":"sec-edgar","filing":"0001179110-21-009557","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911021009557/edgar.xml","form_type":"4"}},{"id":2551520,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-10-04T16:20:01.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":36478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the vesting, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on March 2, 2021."}],"balance_after":71478,"source":{"system":"sec-edgar","filing":"0001179110-21-009149","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911021009149/edgar.xml","form_type":"4"}},{"id":2665856,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T16:20:42.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":170989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the vesting, upon the achievement of a specified organizational milestone, of a portion of a performance-based stock option originally granted on March 2, 2021."}],"balance_after":170989,"derivative":{"exercise_price":45.69,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":170989},"source":{"system":"sec-edgar","filing":"0001179110-21-006780","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911021006780/edgar.xml","form_type":"4"}},{"id":375132,"issuer":{"id":2836,"kind":"organization","name":"THERMO FISHER SCIENTIFIC INC.","symbol":"TMO"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-20T20:09:24.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":438,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1728,"source":{"system":"sec-edgar","filing":"0001127602-21-017562","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97745/000112760221017562/form4.xml","form_type":"4"}},{"id":2808422,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-04T16:17:29.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":196637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 2, 2021 and is scheduled to vest as to one-third of the shares underlying the option when the closing price of the Issuer's common stock, as reported on the Nasdaq Global Select Market, has for 15 consecutive trading days in the five year period following the grant date equaled or exceeded $80.00, $100.00 and $120.00 per share, respectively."}],"balance_after":196637,"derivative":{"exercise_price":45.69,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":196637},"source":{"system":"sec-edgar","filing":"0001179110-21-002869","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911021002869/edgar.xml","form_type":"4"}},{"id":2808421,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-04T16:17:29.000Z","date":"2021-03-02","kind":"purchase","acquired":true,"shares":25000,"price":46.272,"value":1156800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $46.27 to $46.44. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001179110-21-002869","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911021002869/edgar.xml","form_type":"4"}},{"id":3111533,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T16:20:52.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 10, 2020 and is scheduled to vest in full on June 10, 2021."}],"balance_after":11538,"derivative":{"exercise_price":27.49,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001179110-20-007280","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911020007280/edgar.xml","form_type":"4"}},{"id":390205,"issuer":{"id":2836,"kind":"organization","name":"THERMO FISHER SCIENTIFIC INC.","symbol":"TMO"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-21T20:20:59.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":572,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1290,"source":{"system":"sec-edgar","filing":"0001127602-20-017550","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97745/000112760220017550/form4.xml","form_type":"4"}},{"id":3489316,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T16:29:06.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 12, 2019 and is scheduled to vest in full on June 12, 2020."}],"balance_after":11538,"derivative":{"exercise_price":21.74,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001179110-19-007680","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911019007680/edgar.xml","form_type":"4"}},{"id":402809,"issuer":{"id":2836,"kind":"organization","name":"THERMO FISHER SCIENTIFIC INC.","symbol":"TMO"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-23T20:39:44.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":718,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":718,"source":{"system":"sec-edgar","filing":"0001127602-19-019648","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97745/000112760219019648/form4.xml","form_type":"4"}},{"id":3921791,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-22T17:28:32.000Z","date":"2018-05-18","kind":"purchase","acquired":true,"shares":10000,"price":38.0252,"value":380252.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $37.72 to $38.06. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001179110-18-007362","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911018007362/edgar.xml","form_type":"4"}},{"id":3926059,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-18T21:49:01.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":2185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 2,185 restricted stock units vest on April 30, 2019, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,098 restricted stock units granted on August 9, 2017, which vest one-half of the total units on August 9, 2018, one-quarter of the total units on August 9, 2019, and one-quarter of the total units on August 9, 2020, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":7783,"source":{"system":"sec-edgar","filing":"0001127602-18-018177","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218018177/form4.xml","form_type":"4"}},{"id":3980735,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-28T17:25:52.000Z","date":"2018-03-27","kind":"grant","acquired":true,"shares":23076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 27, 2018 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on March 27, 2019 through March 27, 2021."}],"balance_after":23076,"derivative":{"exercise_price":33.18,"expiration_date":"2028-03-26","underlying":"Common Stock","underlying_shares":23076},"source":{"system":"sec-edgar","filing":"0001179110-18-004894","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1226288/000117911018004894/edgar.xml","form_type":"4"}},{"id":4163942,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-11-14T23:03:24.000Z","date":"2017-11-13","kind":"purchase","acquired":true,"shares":2500,"price":67.4531,"value":168632.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average purchase price of the shares purchased.  The shares were purchased at varying prices in the range of $67.32 to $67.59.  The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,098 restricted stock units granted on August 9, 2017, which vest one-half of the total units on August 9, 2018, one-quarter of the total units on August 9, 2019, and one-quarter of the total units on August 9, 2020, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":5598,"source":{"system":"sec-edgar","filing":"0001127602-17-032107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217032107/form4.xml","form_type":"4"}},{"id":4220718,"issuer":{"id":173467,"kind":"organization","name":"Patheon N.V.","symbol":"PTHN"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options (Right to Buy)","published_at":"2017-08-31T18:26:20.000Z","date":"2017-08-29","kind":"disposition_to_issuer","acquired":false,"shares":242885,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The terms of the Option awards provide that options vest in three equal installments on each anniversary of the grant date of March 23, 2017.  Mr. Mullen's employment was terminated by the Issuer immediately following the time of the closing of the tender offer and, pursuant to the terms of the amendment to the Patheon N.V. Omnibus Incentive Plan executed as required by the Purchase Agreement, each unvested option was cancelled and converted into a cash payment equal to the product of (x) the excess of $35.00 over the per Share exercise price of the option, multiplied by (y) the number of Shares subject to the option (rounded down the nearest whole share)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The terms of the Option awards provide that options vest in three equal installments on each anniversary of the grant date of March 23, 2017.  Mr. Mullen's employment was terminated by the Issuer immediately following the time of the closing of the tender offer and, pursuant to the terms of the amendment to the Patheon N.V. Omnibus Incentive Plan executed as required by the Purchase Agreement, each unvested option was cancelled and converted into a cash payment equal to the product of (x) the excess of $35.00 over the per Share exercise price of the option, multiplied by (y) the number of Shares subject to the option (rounded down the nearest whole share)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The terms of the Option awards provide that options vest in three equal installments on each anniversary of the grant date of March 23, 2017.  Mr. Mullen's employment was terminated by the Issuer immediately following the time of the closing of the tender offer and, pursuant to the terms of the amendment to the Patheon N.V. Omnibus Incentive Plan executed as required by the Purchase Agreement, each unvested option was cancelled and converted into a cash payment equal to the product of (x) the excess of $35.00 over the per Share exercise price of the option, multiplied by (y) the number of Shares subject to the option (rounded down the nearest whole share)."}],"balance_after":0,"derivative":{"exercise_price":26.49,"underlying":"Ordinary Shares","underlying_shares":242885},"source":{"system":"sec-edgar","filing":"0001209191-17-050942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1643848/000120919117050942/doc4.xml","form_type":"4"}},{"id":4220717,"issuer":{"id":173467,"kind":"organization","name":"Patheon N.V.","symbol":"PTHN"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2017-08-31T18:26:20.000Z","date":"2017-08-29","kind":"other","acquired":false,"shares":2615089,"price":35,"value":91528115.0,"ownership":{"direct":false,"nature":"By Patheon Holdco Cooperatief U.A. on behalf of the reporting person"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Ordinary shares  of Patheon N.V. (\"Issuer\") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg (\"Purchaser\") and Thermo Fisher Scientific Inc., a Delaware corporation (\"Thermo Fisher\"), to acquire all of the issued and outstanding ordinary shares (the \"Shares\") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the \"Purchase Agreement\"), by and between Issuer, Purchaser and Thermo Fisher."},{"field":"shares","element":"transactionShares","label":"F4","text":"This amount represents ordinary shares held by Patheon Holdco Cooperatief U.A. on behalf of the reporting person. Such Shares were disposed of by Patheon Holdco Cooperatief U.A. pursuant to the tender offer for $35.00 per Share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-050942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643848/000120919117050942/doc4.xml","form_type":"4"}},{"id":4220716,"issuer":{"id":173467,"kind":"organization","name":"Patheon N.V.","symbol":"PTHN"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units (Ordinary Shares)","published_at":"2017-08-31T18:26:20.000Z","date":"2017-08-29","kind":"other","acquired":false,"shares":906858,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This amount represents 906,858 outstanding restricted stock unit awards in respect of Shares that were subject, in whole or in part, to vesting based on the achievement of one or more performance goals (each, a \"PSU\"), whether vested or unvested.  Pursuant to the terms of the Purchase Agreement, 462,177 PSUs were automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to required tax withholding), equal to the product of (i) $35.00 multiplied by (ii) the total number of Shares subject to such PSU award as of immediately prior to the closing of the tender offer (which, in the case of PSUs, was determined based on the actual achievement of performance conditions in accordance with the terms of the award). The remaining 444,681 PSUs were automatically cancelled and forfeited for no consideration in accordance with the terms of the Purchase Agreement and the PSU award."},{"field":"shares","element":"transactionShares","label":"F3","text":"This amount represents 906,858 outstanding restricted stock unit awards in respect of Shares that were subject, in whole or in part, to vesting based on the achievement of one or more performance goals (each, a \"PSU\"), whether vested or unvested.  Pursuant to the terms of the Purchase Agreement, 462,177 PSUs were automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to required tax withholding), equal to the product of (i) $35.00 multiplied by (ii) the total number of Shares subject to such PSU award as of immediately prior to the closing of the tender offer (which, in the case of PSUs, was determined based on the actual achievement of performance conditions in accordance with the terms of the award). The remaining 444,681 PSUs were automatically cancelled and forfeited for no consideration in accordance with the terms of the Purchase Agreement and the PSU award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This amount represents 906,858 outstanding restricted stock unit awards in respect of Shares that were subject, in whole or in part, to vesting based on the achievement of one or more performance goals (each, a \"PSU\"), whether vested or unvested.  Pursuant to the terms of the Purchase Agreement, 462,177 PSUs were automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to required tax withholding), equal to the product of (i) $35.00 multiplied by (ii) the total number of Shares subject to such PSU award as of immediately prior to the closing of the tender offer (which, in the case of PSUs, was determined based on the actual achievement of performance conditions in accordance with the terms of the award). The remaining 444,681 PSUs were automatically cancelled and forfeited for no consideration in accordance with the terms of the Purchase Agreement and the PSU award."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-050942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643848/000120919117050942/doc4.xml","form_type":"4"}},{"id":4220715,"issuer":{"id":173467,"kind":"organization","name":"Patheon N.V.","symbol":"PTHN"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units (Ordinary Shares)","published_at":"2017-08-31T18:26:20.000Z","date":"2017-08-29","kind":"other","acquired":false,"shares":93432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Ordinary shares  of Patheon N.V. (\"Issuer\") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg (\"Purchaser\") and Thermo Fisher Scientific Inc., a Delaware corporation (\"Thermo Fisher\"), to acquire all of the issued and outstanding ordinary shares (the \"Shares\") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the \"Purchase Agreement\"), by and between Issuer, Purchaser and Thermo Fisher."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amount represents 93,432 unvested restricted stock units, each of which represented a contingent right to receive one Share of Issuer.  Mr. Mullen's employment was terminated by the Issuer immediately following the time of the closing of the tender offer and, pursuant to the terms of the amendment to the Patheon N.V. Omnibus Incentive Plan executed as required by the Purchase Agreement, each unvested restricted stock unit award was cancelled and converted into a cash payment equal to the product obtained by multiplying $35.00 by the total number of Shares subject to the restricted stock unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Ordinary shares  of Patheon N.V. (\"Issuer\") were disposed of pursuant to a tender offer by Thermo Fisher (CN) Luxembourg S.a r.l., a private limited liability company (societe a responsabilite limitee) organized under the laws of the Grand Duchy of Luxembourg (\"Purchaser\") and Thermo Fisher Scientific Inc., a Delaware corporation (\"Thermo Fisher\"), to acquire all of the issued and outstanding ordinary shares (the \"Shares\") of Issuer at a purchase price of $35.00 per Share, pursuant to the terms of the Purchase Agreement, dated as of May 15, 2017 (as it may be amended from time to time, the \"Purchase Agreement\"), by and between Issuer, Purchaser and Thermo Fisher."}],"balance_after":906858,"source":{"system":"sec-edgar","filing":"0001209191-17-050942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643848/000120919117050942/doc4.xml","form_type":"4"}},{"id":4236740,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-11T20:40:18.000Z","date":"2017-08-09","kind":"grant","acquired":true,"shares":4126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% of the total award vesting on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant."}],"balance_after":4126,"derivative":{"exercise_price":53.8,"expiration_date":"2027-08-09","underlying":"Common Stock","underlying_shares":4126},"source":{"system":"sec-edgar","filing":"0001127602-17-025505","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217025505/form4.xml","form_type":"4"}},{"id":4236739,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-08-11T20:40:18.000Z","date":"2017-08-09","kind":"grant","acquired":true,"shares":3098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The 3,098 restricted stock units vest 50% of the total award on the first anniversary of the date of grant and 25% of the total award on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant."}],"balance_after":3098,"source":{"system":"sec-edgar","filing":"0001127602-17-025505","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217025505/form4.xml","form_type":"4"}},{"id":4371584,"issuer":{"id":173467,"kind":"organization","name":"Patheon N.V.","symbol":"PTHN"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Options (Right to Buy)","published_at":"2017-03-27T15:22:52.000Z","date":"2017-03-23","kind":"grant","acquired":true,"shares":242885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal installments on each anniversary of the grant date of March 23, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options vest in three equal installments on each anniversary of the grant date of March 23, 2017."}],"balance_after":242885,"derivative":{"exercise_price":26.49,"underlying":"Options (Right to Buy)","underlying_shares":242885},"source":{"system":"sec-edgar","filing":"0001643848-17-000023","document":"wf-form4_149064255564125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643848/000164384817000023/wf-form4_149064255564125.xml","form_type":"4"}},{"id":4371583,"issuer":{"id":173467,"kind":"organization","name":"Patheon N.V.","symbol":"PTHN"},"owners":[{"id":15079,"kind":"person","name":"MULLEN JAMES C","position":1,"cik":"0001226288","reported_name":"MULLEN JAMES C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units (Ordinary Shares)","published_at":"2017-03-27T15:22:52.000Z","date":"2017-03-23","kind":"grant","acquired":true,"shares":93432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest in three equal installments on each anniversary of the grant date of March 23, 2017. Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":1000290,"source":{"system":"sec-edgar","filing":"0001643848-17-000023","document":"wf-form4_149064255564125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643848/000164384817000023/wf-form4_149064255564125.xml","form_type":"4"}}]}